4

Jun, 2018

International Symposium on Zika Virus Research in Marseille – France

Tags: ,

Registrations are now open for the international conference on Zika Virus to be held in Marseille, France, next June. The event – organized by the EU-funded ZIKAlliance project in collaboration with three other EU-funded Zika projects (ZikaPLAN, ZIKAction, and ZIKAVAX) and the European Society for Virology – will take place at the Faculty of Medicine La Timone. The event will provide an overview of the current status of Zika research – covering from basic to clinical research, epidemiology, environmental studies and social sciences – and an opportunity to present the latest results […]

READ MORE

15

Feb, 2018

What we know and what we don’t know about perinatal Zika virus infection: a systematic review

Tags: ,

Authors: Soriano-Arandes A, Rivero-Calle I, Nastouli E, et al. Published in: Expert Review of Anti-infective Therapy Vol. 0, Iss. ja, 2018 Abstract: Zika virus (ZIKV) infection has caused the most challenging worldwide infectious epidemic outbreak in recent months. ZIKV causes microcephaly and other congenital malformations. There is a need to perform updated systematic reviews on ZIKV infection periodically because this epidemic is bringing up new evidence with extraordinary speed.

READ MORE

2

Nov, 2016

The ZIKAction Kick-Off Meeting was a success!

Tags:

The ZIKAction Kick-Off Meeting was held in Kingston, Jamaica at the University of West Indies from October 30th to November 1st. Thank you all for coming!! This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 734857.

READ MORE

21

Oct, 2016

PENTA Foundation coordinated ZIKAction consortium

Tags:

PENTA Foundation coordinated ZIKAction consortium awarded €7 million EU H2020 grant to combat Zika virus and other emerging infectious disease outbreaks The ZIKAction consortium (Preparedness, research and action network on maternal-paediatric axis of Zika virus infection in Latin America and the Caribbean), coordinated by the PENTA Foundation, is set to receive a €7 million, five-year grant from the European Union through the Horizon 2020 programme’s recent call for research to combat Zika virus (ZIKV) and other emerging infections transmitted by mosquitoes in Latin America. This award is one of three […]

READ MORE

17

Jan, 2013

Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children

Tags: ,

Here have been no paediatric randomised trials describing the effect of planned treatment interruptions (PTIs) of antiretroviral therapy (ART) on adherence, or evaluating acceptability of such a strategy. In PENTA 11, HIV-infected children were randomised to CD4-guided PTIs (n = 53) or continuous therapy (CT, n = 56). Carers, and children if appropriate, completed questionnaires on adherence to ART and acceptability of PTIs. There was no difference in reported adherence on ART between CT and PTI groups.

READ MORE